Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

The optimized Cinchonine gel effectively fights acne bacteria and is safe for twice-daily use.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Cyclosporine effectively treated a woman's stubborn skin condition.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Most patients improved with oral contraceptives, but some needed additional treatment.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

The document concludes that measuring γ-glutamyl transpeptidase activity is more accurate with a higher substrate concentration and using diluted acetic acid to stop the reaction.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.